Stocks and Investing Stocks and Investing
Thu, November 18, 2021
Wed, November 17, 2021
Tue, November 16, 2021
Mon, November 15, 2021

Joseph Schwartz Maintained (BMRN) at Buy with Increased Target to $112 on, Nov 15th, 2021


Published on 2024-10-27 18:38:54 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of SVB Leerink, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $108 to $112 on, Nov 15th, 2021.

Joseph has made no other calls on BMRN in the last 4 months.



There are 3 other peers that have a rating on BMRN. Out of the 3 peers that are also analyzing BMRN, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kennen MacKay of "RBC Capital" Maintained at Hold with Increased Target to $88 on, Thursday, July 29th, 2021


These are the ratings of the 2 analyists that currently disagree with Joseph


  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $100 on, Thursday, October 28th, 2021
  • Paul Matteis of "Stifel" Upgraded from Hold to Strong Buy and Increased Target to $96 on, Thursday, September 9th, 2021